Showing results (1611-1620 of 1,996) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|July 17, 2013
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trialJohn Zajicek, Susan Ball, David Wright, et al.
The Lancet. Neurology|July 23, 2013
New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's diseasePaolo Calabresi, Anna Castrioto, Massimiliano Di Filippo, et al.
The Lancet. Neurology|December 5, 2012
Transient isolated brainstem symptoms preceding posterior circulation stroke: a population-based studyNicola L M Paul, Michela Simoni, Peter M Rothwell, et al.
The Lancet. Neurology|December 15, 2012
Neuroendocrine considerations in the treatment of men and women with epilepsyCynthia L Harden, Page B Pennell
The Lancet. Neurology|December 15, 2012
Endoplasmic reticulum dysfunction in neurological diseaseBenoit D Roussel, Antonina J Kruppa, Elena Miranda, et al.
The Lancet. Neurology|January 22, 2013
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkersClifford R Jack, David S Knopman, William J Jagust, et al.
The Lancet. Neurology|December 25, 2012
Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)Peter Ge Kennedy
The Lancet. Neurology|March 24, 2012
Premotor signs and symptoms of multiple system atrophyMilica Jecmenica-Lukic, Werner Poewe, Eduardo Tolosa, et al.
The Lancet. Neurology|March 31, 2012
Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging studyMarkus Färkkilä, Hans-Christoph Diener, Gilles Géraud, et al.
The Lancet. Neurology|March 5, 2013
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial, K E Morrison, S Dhariwal, et al.
Pageof 200